Tunable drug release from blend poly(vinyl pyrrolidone)-ethyl cellulose nanofibers

Copyright © 2019 Elsevier B.V. All rights reserved..

The management of pain and inflammation arising from wounds is essential in obtaining effective healing rates. The application of a wound dressing loaded with an anti-inflammatory drug would enable both issues to be ameliorated, and the aim of this work was to fabricate such a dressing by electrospinning. Fibers comprising ethyl cellulose (EC) and poly(vinyl pyrrolidone) (PVP) loaded with naproxen (Nap) were developed to be used in the early stages of wound care. A family of PVP/EC/Nap systems was prepared by varying the PVP: EC ratio. In all cases, the products of electrospinning comprise non-woven mats of fibers which generally have smooth and cylindrical morphologies. The formulations exist as amorphous solid dispersions, and there appear to be intermolecular interactions between the three components. Adjusting the polymer ratios results in tunable drug release, and formulations have been produced which give zero-order drug release over 20 and 80 h. The fiber mats generated in this work thus have great potential to be used as dressings for the treatment of wound pain and inflammation.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:562

Enthalten in:

International journal of pharmaceutics - 562(2019) vom: 01. Mai, Seite 172-179

Sprache:

Englisch

Beteiligte Personen:

Godakanda, V Umayangana [VerfasserIn]
Li, Heyu [VerfasserIn]
Alquezar, Laura [VerfasserIn]
Zhao, Lixiang [VerfasserIn]
Zhu, Li-Min [VerfasserIn]
de Silva, Rohini [VerfasserIn]
de Silva, K M Nalin [VerfasserIn]
Williams, Gareth R [VerfasserIn]

Links:

Volltext

Themen:

57Y76R9ATQ
7Z8S9VYZ4B
9004-34-6
Anti-Inflammatory Agents, Non-Steroidal
Cellulose
Electrospinning
Ethyl cellulose
FZ989GH94E
Journal Article
Naproxen
Poly(vinyl pyrrolidone)
Povidone
Wound dressing

Anmerkungen:

Date Completed 05.08.2019

Date Revised 05.08.2019

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijpharm.2019.03.035

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM295212519